📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC Guidelines
👉Know your #ESCGuidelines?
A 28-year-old female at nine weeks gestation arrives at ER with shortness of breath, weak and rapid arterial pulses. BP is 70/40 mmHg. ECG shows sinus tachycardia at 120 bpm, s1q3t3 pattern. Chest X-Ray is abnormal.
🔸According to the 2019 ESC Guidelines on Acute Pulmonary Embolism, what should be done next?
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/3b5ovFh
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC Guidelines
👉Know your #ESCGuidelines?
A 28-year-old female at nine weeks gestation arrives at ER with shortness of breath, weak and rapid arterial pulses. BP is 70/40 mmHg. ECG shows sinus tachycardia at 120 bpm, s1q3t3 pattern. Chest X-Ray is abnormal.
🔸According to the 2019 ESC Guidelines on Acute Pulmonary Embolism, what should be done next?
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/3b5ovFh
✨ Join Us✨
📲 @IRathero 💫
📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
According to the 2019 #ESCGuidelines on Dyslipidaemia, ApoB analysis is recommended (Class I recommendation) : ...
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/358GQzg
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
According to the 2019 #ESCGuidelines on Dyslipidaemia, ApoB analysis is recommended (Class I recommendation) : ...
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/358GQzg
✨ Join Us✨
📲 @IRathero 💫
📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸According to the 2019 #ESCGuidelines for the management and treatment of patients with supraventricular tachycardia, which of the below is recommended for patients with atrial tachycardia:
A. Catheter ablation
B. Beta-blockers
C. Amiodarone
D. None of these.
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/2zHGl3o
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸According to the 2019 #ESCGuidelines for the management and treatment of patients with supraventricular tachycardia, which of the below is recommended for patients with atrial tachycardia:
A. Catheter ablation
B. Beta-blockers
C. Amiodarone
D. None of these.
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/2zHGl3o
✨ Join Us✨
📲 @IRathero 💫
📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸A 41-year-old lady continues to show tachycardiomyopathy despite beta blockers and an attempt of ablation. According to the 2019 ESC Guidelines on Supraventricular Tachycardia.
What is the correct management of this patient?
A. Ablate and pacing
B. Add amiodarone
C. Continue monitoring
D. All of these
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/3dni9BA
🖥 https://bit.ly/2YTWRq5
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸A 41-year-old lady continues to show tachycardiomyopathy despite beta blockers and an attempt of ablation. According to the 2019 ESC Guidelines on Supraventricular Tachycardia.
What is the correct management of this patient?
A. Ablate and pacing
B. Add amiodarone
C. Continue monitoring
D. All of these
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/3dni9BA
🖥 https://bit.ly/2YTWRq5
✨ Join Us✨
📲 @IRathero 💫
Forwarded from انجمن آترواسکلروز ایران(IRSA)
📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸A 41-year-old lady continues to show tachycardiomyopathy despite beta blockers and an attempt of ablation. According to the 2019 ESC Guidelines on Supraventricular Tachycardia.
What is the correct management of this patient?
A. Ablate and pacing
B. Add amiodarone
C. Continue monitoring
D. All of these
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/3dni9BA
🖥 https://bit.ly/2YTWRq5
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸A 41-year-old lady continues to show tachycardiomyopathy despite beta blockers and an attempt of ablation. According to the 2019 ESC Guidelines on Supraventricular Tachycardia.
What is the correct management of this patient?
A. Ablate and pacing
B. Add amiodarone
C. Continue monitoring
D. All of these
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/3dni9BA
🖥 https://bit.ly/2YTWRq5
✨ Join Us✨
📲 @IRathero 💫
📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸According to the 2019 ESC/EAS Dyslipidaemia Guidelines, the addition of a PCSK9 inhibitor is recommended for patients already taking a maximally tolerated statin dose and ezetimibe if the LDL-C goal is not achieved:
A. After 4-6 weeks
B. In very-high-risk FH patients
C. For secondary prevention ,in patients at very-high-risk
D. All these patients
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/2ZxK78Q
🖥 https://bit.ly/2AwsON1
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸According to the 2019 ESC/EAS Dyslipidaemia Guidelines, the addition of a PCSK9 inhibitor is recommended for patients already taking a maximally tolerated statin dose and ezetimibe if the LDL-C goal is not achieved:
A. After 4-6 weeks
B. In very-high-risk FH patients
C. For secondary prevention ,in patients at very-high-risk
D. All these patients
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/2ZxK78Q
🖥 https://bit.ly/2AwsON1
✨ Join Us✨
📲 @IRathero 💫
Forwarded from انجمن آترواسکلروز ایران(IRSA)
📚📖#آموزشی : 📚📖
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸According to the 2019 ESC/EAS Dyslipidaemia Guidelines, the addition of a PCSK9 inhibitor is recommended for patients already taking a maximally tolerated statin dose and ezetimibe if the LDL-C goal is not achieved:
A. After 4-6 weeks
B. In very-high-risk FH patients
C. For secondary prevention ,in patients at very-high-risk
D. All these patients
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/2ZxK78Q
🖥 https://bit.ly/2AwsON1
✨ Join Us✨
📲 @IRathero 💫
🚩#Questions and #answers on the 2019 ESC #Guidelines
👉Know your #ESCGuidelines?
🔸According to the 2019 ESC/EAS Dyslipidaemia Guidelines, the addition of a PCSK9 inhibitor is recommended for patients already taking a maximally tolerated statin dose and ezetimibe if the LDL-C goal is not achieved:
A. After 4-6 weeks
B. In very-high-risk FH patients
C. For secondary prevention ,in patients at very-high-risk
D. All these patients
📌#پاسخ فردا در همین کانال 👇
🖥 https://bit.ly/2ZxK78Q
🖥 https://bit.ly/2AwsON1
✨ Join Us✨
📲 @IRathero 💫